메뉴 바로가기 본문 바로가기

Not a Candidate for LASIK or LASEK??

Experience clear, natural vision with EVO+ ICL.
It corrects everything from astigmatism to high myopia without removing corneal tissue,
making it an excellent alternative for patients with thin corneas, dry eyes,
or those who are not suitable candidates for LASIK or LASEK.

EVO ICL: A Cornea-Preserving
Vision Correction Solution

Experience advanced vision correction while preserving your natural cornea.
EVO ICL corrects vision by placing a biocompatible lens behind the iris
without removing or reshaping corneal tissue, providing clear, high-quality vision
for a wide range of refractive errors.

EVO ICL: A Cornea-Preserving
Vision Correction Solution

Experience advanced vision correction while preserving your natural cornea. EVO ICL corrects vision by placing a biocompatible lens behind the iris without removing or reshaping corneal tissue, providing clear, high-quality vision for a wide range of refractive errors.

Advantages of EVO+ ICL

  • All-in-One Vision Correction
    Corrects both myopia and astigmatism in a single procedure.

  • Ideal for Thin Corneas
    A safe option for patients with thin corneas.

  • Rapid Visual Recovery
    Designed for a faster return to daily life.

  • Biocompatible Collamer®
    Made from Collamer®, a proven biocompatible material.

  • Enhanced Night Vision
    Provides clear, sharp vision in low-light conditions.

  • Fully Reversible
    The lens can be removed or exchanged if needed.

  • VISION CORRECTON
  • CLINICAL SAFETY OF EVO ICL

Proven Safety. Trusted Worldwide.
Since its introduction in 1994, EVO ICL has become
one of the world's most trusted and clinically
proven vision correction procedures, with millions of
successful implantations performed worldwide.

CenterFLOW Technology

Developed by STAAR Surgical, CenterFLOW Technology eliminates the need for a preoperative iridotomy,
making the EVO ICL procedure simpler and more comfortable for patients.
The EVO ICL features a 360-μm central port that allows the natural flow
of aqueous humor, eliminating the need for iridotomy while maintaining normal eye physiology.

*Aqueous humor: The clear fluid that fills the front part of the eye.

Advanced Collamer® Material

EVO ICL is made from Collamer®, STAAR Surgical's patented biocompatible material.
Its exceptional biocompatibility allows it to integrate naturally
with the eye, providing long-term comfort, stability, and safety.

Built-in UV Protection

EVO ICL features built-in UV protection that helps block harmful UV rays and protect the eyes.
It also supports clearer vision and visual comfort in low-light conditions

  • VISION CORRECTION
  • EVO ICL Procedure

EVO ICL is a minimally invasive procedure typically
completed in just 10 to 15 minutes.
Most patients experience rapid visual recovery
and can return to their daily activities soon after surgery.
A comprehensive eye examination is performed
beforehand to determine whether EVO ICL is the
right treatment option for you.

  • Surgical Steps

    • 1. A micro-incision of approximately 3 mm is created at the edge of the cornea.

    • 2. The EVO ICL is gently inserted through the micro-incision.

    • 3. The lens is carefully positioned behind the iris using specialized surgical instruments.

  • Surgical Experience

    • Performed by experienced ophthalmologists.

    • Most procedures are completed within 10–15 minutes.

    • Many patients notice clearer vision shortly after the procedure.

    • Designed for a faster return to daily life.

VISION CORRECTION / BENEFITS OF EVO ICL

  • Wide Range of Vision Correction

    Corrects a wide range of refractive errors, from mild to high myopia.

  • Ideal for Dry Eyes

    An excellent option for patients who are not suitable candidates for LASIK or LASEK due to dry eye syndrome.

  • Built-in UV Protection

    Built-in UV protection helps shield your eyes from harmful UVA and UVB rays.

  • Clinically Proven Safety

    Trusted worldwide since 1994, EVO ICL has a long-established record of clinical safety and reliability

  • Rapid Recovery

    A micro-incision of approximately 3 mm promotes faster healing and a quicker return to everyday life.

  • Designed for an Active Lifestyle

    Enjoy the freedom to stay active with confidence in sports, work, and everyday life.

  • Cornea-Preserving Procedure

    No corneal tissue is removed, making it an excellent option for patients with thin corneas.

  • Virtually Invisible

    Positioned behind the iris, the EVO ICL remains virtually invisible after implantation.

  • VISION CORRECTION
  • The Proven Safety of EVO+ ICL

EVO ICL has been clinically proven through decades
of successful outcomes and a long-established safety record since 1994.

900,000

  • 1990    Concept first developed in Russia
  • 1992    Development begins at STAAR Surgical
  • 1994    First ICL procedure performed
  • 1997    ICL receives CE Mark approval in Europe
  • 2002    ICL approved by the Korean Food and Drug Administration (KFDA)
  • 2003    Toric ICL receives CE Mark approval in Europe
  • 2005    Toric ICL approved by the Korean Food and Drug Administration (KFDA)
  • 2011    EVO ICL and EVO Toric ICL receive CE Mark approval in Europe
  • 2013    EVO ICL and EVO Toric ICL approved by the Ministry of Food and Drug Safety (MFDS)
  • 2018    Over 900,000 ICL procedures performed worldwide

Looking for an Alternative
to LASIK or LASEK?

Discover personalized vision correction with
EVO ICL—designed to preserve your natural cornea.

Book Your Consultation
닫기